Related Experiment Video
Updated: Jun 13, 2026
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Elevated red cell distribution width as a prognostic indicator in critically ill patients with atrial fibrillation
Yunquan Zhao1, Weiwei Pan1, Degang Mo2
1Department of Cardiology, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, 266000, China.
Background:
Red cell distribution width (RDW) has emerged as an important prognostic biomarker in various cardiovascular and renal conditions. However, its specific role in critically ill patients with coexisting atrial fibrillation (AF) and chronic kidney disease (CKD) is not well established. This study aims to evaluate the prognostic significance of RDW in this population.
Methods:
We conducted a retrospective cohort study using the Medical Information Mart for Intensive Care-IV (MIMIC-IV) database, identifying 2208 patients with concomitant AF and CKD. We assessed the association between RDW levels and 28-day and 365-day mortality using multivariable Cox regression models, Kaplan-Meier survival analysis, receiver operating characteristic (ROC) curve and subgroup analyses.
Results:
Elevated RDW was independently associated with increased risks of both 28-day and 365-day all-cause mortality after multivariable adjustment (fully adjusted Hazard Ratio [HR]: 1.15 and 1.17; all p < 0.001). Patients in the highest RDW quartile demonstrated the greatest mortality risk, with an adjusted HR of 2.46 for 28-day mortality and 2.65 for 365-day mortality. Kaplan-Meier analysis revealed significantly lower survival probabilities in higher RDW quartiles (log-rank test: p < 0.001). ROC analysis demonstrated fair predictive accuracy for RDW (Area Under the Curve [AUC]: 0.64 for 28-day and 0.68 for 365-day mortality), with optimal cut-off values of 15.35% and 15.55%, respectively. Subgroup analyses confirmed the consistent prognostic value of RDW across most patient strata and identified significant interactions with CKD stage (p for interaction < 0.001) and type 2 diabetes (p for interaction = 0.048).
Conclusion:
RDW is a valuable prognostic biomarker for identifying patients with AF and CKD who are at increased risk of both short- and long-term mortality. This supports its use in risk stratification to guide timely interventions and personalized management.
Clinical Trial Number:
not applicable.
Related Concept Videos
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
01:17Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
01:22Acute Kidney Injury I: Introduction
01:11Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:24Chronic Kidney Disease II: Clinical Manifestations